Medicines have made an appreciable contribution to improving health. However, even high-
income countries are struggling to fund new premium-priced medicines. This will grow …

Objectives Evidence-based decision-making is the sine qua non for safe and effective
patient care and the long-term functioning of health systems. Since 2020 Digital Health …

Background It has been suggested that differences in health technology assessment (HTA)
processes among countries, particularly within Europe, have led to inequity in patient access …

Background: Identifying treatments that offer value and value for money is becoming
increasingly important, with interest in how health technology assessment (HTA) and …

Background Little is known on the performance of the newly introduced health benefit
assessment process, AMNOG, in Germany compared to other health technology …

Abstract Objectives Many European countries regulate the markets for prescription drugs in
order to cope with rising health expenditures. On the other hand, regulation distorts …

Background Policy-makers can use a menu of pharmaceutical policy options. This study
aimed to survey these measures that were implemented in European countries between …

Context Digital health applications that support patients in managing their condition can
have a positive impact on patients' health and improve the overall care process. In late 2019 …

Objective Our aim was to explore trends in price evolution and prescription volumes of
anticonvulsants (AEDs, antiepileptic drugs) in Germany between 2000 and 2017. Method …

Background Rapidly evolving socioeconomic and technological trends make it challenging
to improve access, effectiveness and efficiency in the use of pharmaceuticals. This paper …